Long-Term Clinical Safety of the Ad26.ZEBOV and MVA-BN-Filo Ebola Vaccines: A Prospective, Multi-Country, Observational Study

In this prospective, observational study (ClinicalTrials.gov Identifier: NCT02661464), long-term safety information was collected from participants previously exposed to the Ebola vaccines Ad26.ZEBOV and/or MVA-BN-Filo while enrolled in phase 1, 2, or 3 clinical studies. The study was conducted at 1...

Cijeli opis

Bibliografski detalji

Glavni autori:	Adeep Puri, Andrew J. Pollard, Catherine Schmidt-Mutter, Fabrice Lainé, George PrayGod, Hannah Kibuuka, Houreratou Barry, Jean-François Nicolas, Jean-Daniel Lelièvre, Sodiomon Bienvenu Sirima, Beatrice Kamala, Daniela Manno, Deborah Watson-Jones, Auguste Gaddah, Babajide Keshinro, Kerstin Luhn, Cynthia Robinson, Macaya Douoguih
Format:	Artigo
Jezik:	Inglês
Izdano:	MDPI AG 2024-02-01
Serija:	Vaccines
Teme:	Ebola virus Ad26.ZEBOV MVA-BN-Filo vaccines clinical trials safety
Online pristup:	https://www.mdpi.com/2076-393X/12/2/210
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!